Day 2 Antigen tests on sale now. Click here.
-
Shop
-
Goal
- Visit Local Test Pod
-
Learn
-
Enterprise
The team behind the technology
Project Screen by Prenetics is an initiative developed by Prenetics, a healthcare company with headquarters in London and Hong Kong.
Read More
Prenetics leadership team
Danny Yeung
Group CEO & Co-Founder Prenetics & CircleDNA
Avi Lasarow
CEO Prenetics EMEA & DNAfit, Hon. Consul South Africa to UK
Andrew Steele
Head of Product Prenetics EMEA & DNAfit
Rio Ferdinand
Subject Matter Expert Prenetics EMEA & DNAfit
Stan Tang
Head of PMO
Dr. Anna Mitchell
Head of Clinical Governance and Testing
Brian Stephenson
VP Market Development
Jotika Behari
Head of Risk & Compliance
Prenetics’ expert scientific consortium
Dr. Rachel Liebmann
Group Medical Director, The Doctor’s Laboratory and Vice President of the Royal College of Pathologists
Dr. Mark Atkin
Consultant Virologist, The Doctor’s Laboratory
Dr. Senthil Sundaram, MD
Chief Clinical Officer at Prenetics; Leads clinical development of molecular genetic testing
Dr. Lawrence Tzang CH, BSc, PhD, Reg MLT
Chief Scientific Officer & Laboratory Director of Prenetics COVID-19 Screening Facility
Scientific working group
Prof. Alan McNally, BSC, PhD
Director of Institute of Microbiology and Infection, University of Birmingham
Prof. Willem Van Schaik, MSc, PhD
Institute of Microbiology and infection, University of Birmingham
Prof. Michael M Yang, PhD
Head and Chair Professor, Department of Biomedical Sciences at City University of Hong Kong
Dr. Richard H. Kaszynski, M.A, M.D,PhD
Co-Founder: Stanford Solutions, a healthcare innovation group founded out of Standard University School of Medicine. Executive Director, Shinwakai Medical Group, Tokyo, Japan
